These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7542855)

  • 1. The hepatitis nucleocapsid as a vaccine carrier moiety.
    Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
    Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.
    Schödel F; Wirtz R; Peterson D; Hughes J; Warren R; Sadoff J; Milich D
    J Exp Med; 1994 Sep; 180(3):1037-46. PubMed ID: 7520465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
    Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge.
    Schödel F; Peterson D; Milich DR; Charoenvit Y; Sadoff J; Wirtz R
    Behring Inst Mitt; 1997 Feb; (98):114-9. PubMed ID: 9382731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunogenicity of hepatitis B virus core and E antigens.
    Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
    J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
    Chen X; Li M; Le X; Ma W; Zhou B
    Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A malaria vaccine candidate based on a hepatitis B virus core platform.
    Sällberg M; Hughes J; Jones J; Phillips TR; Milich DR
    Intervirology; 2002; 45(4-6):350-61. PubMed ID: 12602355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
    J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.
    Billaud JN; Peterson D; Lee BO; Maruyama T; Chen A; Sallberg M; Garduño F; Goldstein P; Hughes J; Jones J; Milich D
    Vaccine; 2007 Feb; 25(9):1593-606. PubMed ID: 17178179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.
    von Brunn A; Brand M; Reichhuber C; Morys-Wortmann C; Deinhardt F; Schödel F
    Vaccine; 1993; 11(8):817-24. PubMed ID: 7689283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection.
    Schödel F; Neckermann G; Peterson D; Fuchs K; Fuller S; Will H; Roggendorf M
    Vaccine; 1993; 11(6):624-8. PubMed ID: 8322485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.
    Street M; Herd K; Londono P; Doan T; Dougan G; Kast WM; Tindle RW
    Arch Virol; 1999; 144(7):1323-43. PubMed ID: 10481740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.